Literature DB >> 29523054

White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.

B Cannerfelt1, J Nystedt2,3,4, A Jönsen5, J Lätt6, D van Westen1,3, A Lilja1, A Bengtsson5, P Nilsson2, J Mårtensson1, P C Sundgren1,3.   

Abstract

Aim The aim of this study was to evaluate the extent of white matter lesions, atrophy of the hippocampus and corpus callosum, and their correlation with cognitive dysfunction (CD), in patients diagnosed with systemic lupus erythematosus (SLE). Methods Seventy SLE patients and 25 healthy individuals (HIs) were included in the study. To evaluate the different SLE and neuropsychiatric SLE (NPSLE) definition schemes, patients were grouped both according to the American College of Rheumatology (ACR) definition, as well as the more stringent ACR-Systemic Lupus International Collaborating Clinics definition. Patients and HIs underwent a 3 Tesla brain MRI and a standardized neuropsychological test. MRI data were evaluated for number and volume of white matter lesions and atrophy of the hippocampus and corpus callosum. Differences between groups and subgroups were evaluated for significance. Number and volume of white matter lesions and atrophy of the hippocampus and corpus callosum were correlated to cognitive dysfunction. Results The total volume of white matter lesions was significantly larger in SLE patients compared to HIs ( p = 0.004). However, no significant differences were seen between the different SLE subgroups. Atrophy of the bilateral hippocampus was significantly more pronounced in patients with NPSLE compared to those with non-NPSLE (right: p = 0.010; left p = 0.023). Significant negative correlations between cognitive test scores on verbal memory and number and volume of white matter lesions were present. Conclusion SLE patients have a significantly larger volume of white matter lesions on MRI compared to HIs and the degree of white matter lesion volume correlates to cognitive dysfunction, specifically to verbal memory. No significant differences in the number or volume of white matter lesions were identified between subgroups of SLE patients regardless of the definition model used.

Entities:  

Keywords:  MRI; Systemic Lupus International Collaborating Clinics (SLICC); brain atrophy; cognitive dysfunction; neuropsychiatric systemic lupus erythematosus; systemic lupus erythematosus; white matter burden; white matter hyperintensities; white matter lesions; white matter load

Mesh:

Year:  2018        PMID: 29523054     DOI: 10.1177/0961203318763533

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Authors:  Meggan Mackay; An Vo; Chris C Tang; Michael Small; Erik W Anderson; Elisabeth J Ploran; Justin Storbeck; Brittany Bascetta; Simran Kang; Cynthia Aranow; Carl Sartori; Philip Watson; Bruce T Volpe; Betty Diamond; David Eidelberg
Journal:  JCI Insight       Date:  2019-01-10

Review 2.  Multiple Sclerosis: Diagnosis and Differential Diagnosis.

Authors:  Sami Ömerhoca; Sinem Yazici Akkaş; Nilüfer Kale İçen
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 3.  Pathophysiology of cognitive dysfunction and the role of combined brain/heart magnetic resonance imaging (Review).

Authors:  George Markousis-Mavrogenis; Flora Bacopoulou; Genovefa Kolovou; Maria-Roser Pons; Aikaterini Giannakopoulou; Antigoni Papavasiliou; George D Kitas; George P Chrousos; Sophie I Mavrogeni
Journal:  Exp Ther Med       Date:  2022-07-14       Impact factor: 2.751

4.  Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study.

Authors:  Kristoffer A Zervides; Andreas Jern; Jessika Nystedt; Birgitta Gullstrand; Petra C Nilsson; Pia C Sundgren; Anders A Bengtsson; Andreas Jönsen
Journal:  BMC Rheumatol       Date:  2022-07-09

Review 5.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

Review 6.  Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus.

Authors:  Meggan Mackay; Chris C Tang; An Vo
Journal:  Curr Opin Neurol       Date:  2020-06       Impact factor: 5.710

7.  Structural Changes on MRI Demonstrate Specific Cerebellar Involvement in SLE Patients-A VBM Study.

Authors:  Johan Mårtensson; Theodor Rumetshofer; Jessika Nystedt; Jimmy Lätt; Petra Nilsson; Anders Bengtsson; Andreas Jönsen; Pia C Sundgren
Journal:  Brain Sci       Date:  2021-04-16

8.  Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study.

Authors:  L Langensee; J Mårtensson; A Jönsen; K Zervides; A Bengtsson; J Nystedt; B Cannerfelt; P Nilsson; P Mannfolk; J Lätt; T Rumetshofer; P C Sundgren
Journal:  BMC Rheumatol       Date:  2022-04-20

Review 9.  Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus.

Authors:  Erica Moore; Michelle W Huang; Chaim Putterman
Journal:  Curr Opin Rheumatol       Date:  2020-03       Impact factor: 4.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.